Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs XPO✓SelectedUSD · XPOGSK vs XPO performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs XPO

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
XPO return
+99.0%
Excess return
-46.2%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioXPOExcessAlpha
1D-0.1%-3.7%+3.6%+0.2%
7D-5.3%-9.5%+4.2%-4.6%
30D-3.7%-7.4%+3.8%-3.1%
3M-7.3%-11.4%+4.1%-6.5%
6M-4.2%-17.2%+13.0%-3.1%
YTD+0.9%+28.3%-27.5%-0.5%
1Y+7.3%+38.8%-31.6%+5.4%
3Y+52.7%+97.5%-44.7%+46.1%
All+52.7%+99.0%-46.2%+46.1%

Cumulative growth

Daily Returns

Daily percentage return beside XPO.

Daily Out/Under-Performance

Portfolio return minus XPO return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × XPO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded XPO wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling